[Antithrombin III: critical review of the methods used for its monitoring in thrombophilic states].
D000925:Anticoagulants / Q000627:therapeutic use; D000990:Antithrombin III / Q000032:analysis*; D001778:Blood Coagulation Disorders / Q000175:diagnosis*; D003327:Coronary Disease / Q000097:blood; D003920:Diabetes Mellitus / Q000097:blood; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood; D006973:Hypertension / Q000097:blood; D007158:Immunologic Techniques; D008722:Methods; D008991:Monitoring, Physiologic; D009369:Neoplasms / Q000097:blood; D009404:Nephrotic Syndrome / Q000097:blood; D012306:Risk; D013924:Thrombophlebitis / Q000097:blood; D013927:Thrombosis / Q000175:diagnosis*
D000925:Anticoagulants; D000990:Antithrombin III
Antitrombina III: revisione critica delle metodiche in uso per il monitoraggio degli stati trombofilici.